强耀生物科技
强耀生物
强耀生物
强耀生物科技version: English | 中文版
强耀生物科技
强耀生物科技
Online Service 
强耀生物科技
强耀生物科技
Scan For WeChat
强耀生物科技
Phone Web

Services
Products强耀生物科技
强耀生物
Your location:Home>> Products >> Hot Polypeptide

强耀生物科技 Calcitonin, Salmon
Name Calcitonin, Salmon
Other Name Thyrocalcitonin
Sequence (Single letter abbreviations) CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2
Sequence(Three letter abbreviations) {CYS}{SER}{ASN}{LEU}{SER}{THR}{CYS}{VAL}{LEU}{GLY}{LYS}{LEU}{SER}{GLN}{GLU}{LEU}{HIS}{LYS}{LEU}{GLN}{THR}{TYR}{PRO}{ARG}{THR}{ASN}{THR}{GLY}{SER}{GLY}{THR}{PRO}-NH2
C-port NH2
Chemical bridge Disulfide bridge: Cys1-Cys7
Basic description Calcitonin (salmon) is an hypocalcemic hormone produced by the parafollicular C cells of the thyroid or by the ultimobranchial bodies of nonmammalian vertebrates. Calcitonin decreases blood calcium and phosphate due to inhibition of resorption by osteoblasts and osteocytes. Calcitonin contains a single disulfide bond, which causes the amino terminus to assume the shape of a ring. Alternative splicing of the calcitonin pre-mRNA can yield a mRNA encoding calcitonin gene-related peptide; that peptide appears to function in the nervous and vascular systems. The calcitonin receptor has been cloned and shown to be a member of the seven-transmembrane, G protein-coupled receptor family.
Solubility Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
The molecular weight 3431.900
Chemical formula C145H240N44O48S2
The purity > 95%
Storage conditions Store at -20°C.
Annotation Calcitonin is a 32 amino acid polypeptide, 8 of which are conserved across all species.
Documents 文档
Figures 文档
Reference Schweitzer-Stenner R, et al. Salmon calcitonin and amyloid beta: two peptides with amyloidogenic capacity adopt different conformational manifolds in their unfolded states. Biochemistry. Mar 2006; 45(9): 2810-2819. Sahin F, et al. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin. Rheumatol. Mar 2006; 25(2): 143-148. Ofluoglu D, et al. Early effect of nasal salmon calcitonin on the bone marker Crosslaps. Rheumatol. Int. Feb 2006; 26(4): 288-291.


Contact Us    |    Jobs    |    About Us    |    My Account   
TEL:021-50795728 0512-63930660 E-MAIL: outside@ChinaPeptides.com
COPYRIGHT © 2009 ChinaPeptides CORPORATION. ALL RIGHTS RESERVED